| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/B978-0-12-418700-9.00009-5 |
| P8608 | Fatcat ID | release_yoy4kon44jc73cwld3lpetbbsi |
| P3181 | OpenCitations bibliographic resource ID | 2762947 |
| P698 | PubMed publication ID | 24290389 |
| P50 | author | Elaine Hsiao | Q90658230 |
| P2860 | cites work | The Role of Epilepsy and Epileptiform EEGs in Autism Spectrum Disorders | Q22241670 |
| Maternal infection and immune involvement in autism | Q22252357 | ||
| The role of immune dysfunction in the pathophysiology of autism | Q22252518 | ||
| Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders | Q22252629 | ||
| Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways | Q24306625 | ||
| Aggression in children and adolescents with ASD: prevalence and risk factors | Q50301804 | ||
| Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells | Q50302175 | ||
| A prospective, open-label trial of galantamine in autistic disorder | Q50302443 | ||
| Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda | Q50304111 | ||
| Autism as one of several disabilities in two children with congenital cytomegalovirus infection | Q50306692 | ||
| Brief report: autistic disorder in three children with cytomegalovirus infection | Q50307013 | ||
| Reduced natural killer cell activity in autism | Q50308336 | ||
| Macrocephaly in autism and other pervasive developmental disorders | Q50312088 | ||
| Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism | Q50313816 | ||
| A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders | Q50344544 | ||
| Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets. | Q54573954 | ||
| Peripheral lymphoid development and function in TCR mutant mice | Q72772774 | ||
| Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils | Q82874747 | ||
| Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. | Q37332233 | ||
| Elevated immune response in the brain of autistic patients | Q37405256 | ||
| In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. | Q37482487 | ||
| Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits | Q37529899 | ||
| Cytokines and CNS development | Q37617628 | ||
| Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression | Q37724642 | ||
| Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin | Q37731383 | ||
| Key role for gene dosage and synaptic homeostasis in autism spectrum disorders | Q37770646 | ||
| Medical comorbidities in autism: challenges to diagnosis and treatment | Q37774101 | ||
| Comparative immunogenetics of autism and schizophrenia | Q37886065 | ||
| Autoantibodies associated with diseases of the CNS: new developments and future challenges | Q37903490 | ||
| The role of microglia in the healthy brain. | Q37954595 | ||
| Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain | Q36146434 | ||
| High complement factor I activity in the plasma of children with autism spectrum disorders. | Q36168539 | ||
| HLA Immune Function Genes in Autism | Q36169472 | ||
| Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction | Q36205011 | ||
| Immune system gene dysregulation in autism and schizophrenia. | Q36213513 | ||
| Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder | Q36227900 | ||
| Major histocompatibility complex class I proteins in brain development and plasticity. | Q36384439 | ||
| Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring | Q36394775 | ||
| Immune-neural connections: how the immune system's response to infectious agents influences behavior | Q36447409 | ||
| Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia | Q36486414 | ||
| Maternal autoantibodies in autism | Q36647085 | ||
| Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder | Q36741348 | ||
| Elevated maternal C-reactive protein and autism in a national birth cohort | Q36787986 | ||
| Sex-biased gene expression in the developing brain: implications for autism spectrum disorders | Q36843354 | ||
| Frank A. Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system | Q36888123 | ||
| Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report | Q36892242 | ||
| Behavioral correlates of maternal antibody status among children with autism | Q36913428 | ||
| Autism-specific maternal autoantibodies recognize critical proteins in developing brain | Q37065269 | ||
| Altered gene expression and function of peripheral blood natural killer cells in children with autism | Q37085371 | ||
| Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms | Q37146599 | ||
| Immune transcriptome alterations in the temporal cortex of subjects with autism. | Q37218842 | ||
| Macrophage migration inhibitory factor and autism spectrum disorders | Q37277595 | ||
| Immune system in the brain: a modulatory role on dendritic spine morphophysiology? | Q38006707 | ||
| Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders | Q38021432 | ||
| Placental regulation of maternal-fetal interactions and brain development | Q38023292 | ||
| Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology | Q38093878 | ||
| Progress toward treatments for synaptic defects in autism | Q38112617 | ||
| Microglial regulation of cholinergic differentiation in the basal forebrain | Q39478174 | ||
| Gene and miRNA expression profiles in autism spectrum disorders | Q39651877 | ||
| Autoantibodies to cerebellum in children with autism associate with behavior | Q39809070 | ||
| MHC class I: an unexpected role in neuronal plasticity | Q42115670 | ||
| Of mice and humans: how good are HLA transgenic mice as a model of human immune responses? | Q42157643 | ||
| Gene expression changes in children with autism | Q42637136 | ||
| Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation | Q42736872 | ||
| Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test | Q43191771 | ||
| Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis. | Q43266917 | ||
| Autism in children with congenital rubella | Q43582958 | ||
| IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. | Q43678528 | ||
| Epigenetic changes at gene promoters in response to immune activation in utero | Q43708625 | ||
| D-cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice | Q43719549 | ||
| Effect of risperidone on serum cytokines | Q43932141 | ||
| Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons | Q44030596 | ||
| A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder | Q44213125 | ||
| Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome | Q44307239 | ||
| Association of family history of autoimmune diseases and autism spectrum disorders. | Q44723499 | ||
| A pilot study of D-cycloserine in subjects with autistic disorder | Q45130115 | ||
| Cluster analysis of autistic patients based on principal pathogenetic components | Q45261664 | ||
| Maternal infection and autism. | Q46028338 | ||
| Autism spectrum disorders: from immunity to behavior | Q46308489 | ||
| A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins | Q46308632 | ||
| Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. | Q46311342 | ||
| Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms | Q46485124 | ||
| The link between some alleles on human leukocyte antigen system and autism in children. | Q46635749 | ||
| Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid | Q46658116 | ||
| Microglia in the cerebral cortex in autism | Q46799636 | ||
| Infection in the first 2 years of life and autism spectrum disorders | Q46842954 | ||
| Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism | Q46846718 | ||
| Effects of fluoxetine on cellular immune response in stressed mice | Q46858923 | ||
| Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model | Q48017998 | ||
| Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism | Q48104813 | ||
| Microglial activation in young adults with autism spectrum disorder | Q48165642 | ||
| Possible association between congenital cytomegalovirus infection and autistic disorder | Q48205787 | ||
| Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism | Q48221643 | ||
| Adaptive immunity affects learning behavior in mice | Q48361938 | ||
| Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic Poly I:C at mid-pregnancy | Q48383895 | ||
| The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. | Q48448425 | ||
| Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. | Q48666471 | ||
| Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. | Q48716701 | ||
| Autoimmune thyroid disease: unlocking a complex puzzle | Q33347169 | ||
| Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines | Q33865755 | ||
| Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model | Q33897613 | ||
| Sibling recurrence and the genetic epidemiology of autism | Q34141369 | ||
| Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice | Q34150003 | ||
| Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages | Q34211584 | ||
| The co-morbidity burden of children and young adults with autism spectrum disorders | Q34236692 | ||
| Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study | Q34273108 | ||
| Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder | Q34282952 | ||
| Modifiable risk factors for schizophrenia and autism--shared risk factors impacting on brain development | Q34309793 | ||
| Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia | Q34335485 | ||
| Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome | Q34348399 | ||
| Brain transcriptional and epigenetic associations with autism | Q34416063 | ||
| Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders | Q34506868 | ||
| Structural, genetic, and functional signatures of disordered neuro-immunological development in autism spectrum disorder | Q34512200 | ||
| Maternal neuronal antibodies associated with autism and a language disorder | Q34532394 | ||
| Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism | Q34588189 | ||
| Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders | Q34645392 | ||
| Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders | Q34689823 | ||
| Past and future perspectives in autism epidemiology | Q34763203 | ||
| Network topologies and convergent aetiologies arising from deletions and duplications observed in individuals with autism | Q34765356 | ||
| Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes | Q34818778 | ||
| Childhood serum anti-fetal brain antibodies do not predict autism | Q35002411 | ||
| Characteristics and concordance of autism spectrum disorders among 277 twin pairs | Q35006683 | ||
| IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation | Q35044553 | ||
| Parental autoimmune diseases associated with autism spectrum disorders in offspring | Q35047183 | ||
| Placental TNF-α signaling in illness-induced complications of pregnancy | Q35071279 | ||
| A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children | Q35123969 | ||
| The major histocompatibility complex and autism spectrum disorder. | Q35193880 | ||
| Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study | Q35671064 | ||
| Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression | Q35844122 | ||
| Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response | Q35889855 | ||
| Effects of maternal immune activation on gene expression patterns in the fetal brain | Q35913929 | ||
| Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway | Q35944934 | ||
| Elevated serum levels of interleukin-17A in children with autism. | Q36136811 | ||
| T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions | Q24562400 | ||
| Hematopoietic origin of pathological grooming in Hoxb8 mutant mice | Q24624921 | ||
| Maternal and fetal antibrain antibodies in development and disease | Q24625610 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| Fragile X syndrome and targeted treatment trials | Q26865162 | ||
| Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism | Q27005851 | ||
| Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment | Q27011394 | ||
| Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions | Q28236917 | ||
| Infantile autism: a genetic study of 21 twin pairs | Q28254263 | ||
| The complement system: an unexpected role in synaptic pruning during development and disease | Q28269217 | ||
| Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia | Q28275426 | ||
| A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden | Q28277400 | ||
| Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice | Q28286419 | ||
| Autism as a strongly genetic disorder: evidence from a British twin study | Q28303915 | ||
| Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis | Q28475568 | ||
| Connecting genes to brain in the autism spectrum disorders | Q28705565 | ||
| In search of cellular immunophenotypes in the blood of children with autism | Q28740461 | ||
| MHC signaling during social communication | Q28834594 | ||
| Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies | Q28943260 | ||
| Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism | Q29029006 | ||
| Transcriptomic analysis of autistic brain reveals convergent molecular pathology | Q29614877 | ||
| Neuroglial activation and neuroinflammation in the brain of patients with autism | Q29619689 | ||
| Wild-type microglia arrest pathology in a mouse model of Rett syndrome | Q30424614 | ||
| Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development | Q30435550 | ||
| Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism | Q30454923 | ||
| Modeling an autism risk factor in mice leads to permanent immune dysregulation | Q30458844 | ||
| Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring | Q30458917 | ||
| Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. | Q30467965 | ||
| Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology | Q30472080 | ||
| Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats | Q30497096 | ||
| Neurobehavioral changes resulting from recombinase activation gene 1 deletion | Q30531755 | ||
| Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors | Q30573268 | ||
| Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder | Q30587531 | ||
| Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey | Q30654306 | ||
| Aberrant immune responses in a mouse with behavioral disorders | Q31025723 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism spectrum disorder | Q1436063 |
| autism | Q38404 | ||
| P304 | page(s) | 269-302 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | International Review of Neurobiology | Q15754273 |
| P1476 | title | Immune Dysregulation in Autism Spectrum Disorder | |
| P478 | volume | 113 |
| Q47312938 | A single dose of trichloroethylene given during development does not substantially alter markers of neuroinflammation in brains of adult mice. |
| Q35631733 | Control of brain development, function, and behavior by the microbiome |
| Q38299791 | Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology |
| Q38226805 | Convergent synaptic and circuit substrates underlying autism genetic risks |
| Q90706593 | Do Alarmins Have a Potential Role in Autism Spectrum Disorders Pathogenesis and Progression? |
| Q34679392 | Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder |
| Q64869644 | Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. |
| Q38550206 | Immune mediators in the brain and peripheral tissues in autism spectrum disorder |
| Q42378870 | Immuno-psychiatry: an agenda for clinical practice and innovative research |
| Q55079878 | Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum. |
| Q54982081 | Interplay Between Peripheral and Central Inflammation in Autism Spectrum Disorders: Possible Nutritional and Therapeutic Strategies. |
| Q34366837 | Irritable bowel syndrome: a microbiome-gut-brain axis disorder? |
| Q91970964 | Maternal Immune Activation and Related Factors in the Risk of Offspring Psychiatric Disorders |
| Q89832023 | Maternal stressors and the developmental origins of neuropsychiatric risk |
| Q37653680 | Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches |
| Q35691567 | Microbiota and the gut-brain axis |
| Q47850433 | Microglia and neonatal brain injury. |
| Q28241240 | Minireview: Gut microbiota: the neglected endocrine organ |
| Q38981245 | Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome |
| Q38977281 | Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking? |
| Q60500705 | Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders |
| Q38728728 | Prenatal fever and autism risk |
| Q42363818 | Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report |
| Q33788661 | Risk factors in autism: Thinking outside the brain |
| Q50418499 | Saccadic eye movements in adults with high-functioning autism spectrum disorder |
| Q88650068 | The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective |
| Q35646482 | The Role of Epigenetic Change in Autism Spectrum Disorders. |
| Q89477390 | The Role of Gluten in Autism |
| Q28276657 | The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease |
| Q90330837 | The inflammatory event of birth: How oxytocin signaling may guide the development of the brain and gastrointestinal system |
Search more.